Chris Halyk
Director/Board Member at MEDIPHARM LABS CORP.
Net worth: 4 988 $ as of 31/05/2024
Chris Halyk active positions
Companies | Position | Start | End |
---|---|---|---|
MEDIPHARM LABS CORP. | Director/Board Member | 04/08/2020 | - |
Independent Dir/Board Member | 04/08/2020 | - |
Career history of Chris Halyk
Former positions of Chris Halyk
Companies | Position | Start | End |
---|---|---|---|
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | President | 01/01/2006 | 01/01/2019 |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Director/Board Member | 01/01/2012 | 01/01/2013 |
Ortho Biotech, Inc. | Corporate Officer/Principal | - | - |
Training of Chris Halyk
Richard Ivey School of Business | Undergraduate Degree |
Statistics
International
Canada | 5 |
United States | 2 |
Operational
Director/Board Member | 2 |
President | 1 |
Independent Dir/Board Member | 1 |
Sectoral
Commercial Services | 2 |
Health Technology | 2 |
Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MEDIPHARM LABS CORP. | Process Industries |
Private companies | 3 |
---|---|
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
Ortho Biotech, Inc. |
- Stock Market
- Insiders
- Chris Halyk
- Experience